Product Information
OLMESARTAN-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB is a generic product labeled by Solco Healthcare US LLC, priced at $0.1817 per EA under NDC 43547039103. Its NADAC has been published 474 times since May 31, 2017.
OLMESARTAN-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB
olmesartan medoxomil and hydrochlorothiazideStrength
12.5; 20 mg/1; mg/1
Manufacturer
Solco Healthcare US LLCNDC
43547039103
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMILApproval Type
Generic (ANDA)
FDA Application
ANDA207804On Market Since
4/24/2017
Pharmacological Classes
Price Statistics
The NADAC for OLMESARTAN-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB has been published 474 times since May 31, 2017, and over the history we have for it it has declined 95.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1817 per EA |
|---|---|
| All-time high | $3.7489 (Jun 14, 2017) |
| All-time low | $0.1437 (Oct 17, 2018) |
| 52-week high | $0.1999 |
| 52-week low | $0.1669 |
| Median price | $0.1997 |
| Average price | $0.2666 |
| Largest weekly change | -93.3% (Jul 19, 2017) |
| Weeks tracked | 474 |
| Tracking since | May 31, 2017 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of OLMESARTAN-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for OLMESARTAN-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB, manufactured by Solco Healthcare US LLC, is $0.1817 per EA (NDC 43547039103), effective Jun 24, 2026.
How has the price of OLMESARTAN-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB changed over time?
Over the history we have for it, the NADAC for OLMESARTAN-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB has declined 95.2%. It has been tracked across 474 weekly CMS publications since May 31, 2017.
What are the highest and lowest recorded NADAC prices for OLMESARTAN-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB?
Since May 31, 2017, the NADAC for OLMESARTAN-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB has ranged from a low of $0.1437 (Oct 17, 2018) to a high of $3.7489 (Jun 14, 2017), with a median of $0.1997 per EA.
Are there cheaper alternatives to OLMESARTAN-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as OLMESARTAN-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB, but none are currently priced below it.
Who manufactures OLMESARTAN-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB?
OLMESARTAN-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB (NDC 43547039103) is labeled by Solco Healthcare US LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification